3 results
Approved WMOPending
To evaluate the safety and tolerability of crovalimab compared witheculizumab
Approved WMORecruiting
Circulating CriPec docetaxel nanoparticles are designed to be in a higher degree than the original compound (docetaxel) to be trapped in tumor tissue due to the enhanced penetration and retention (EPR) effect. Subsequent release of docetaxel from…
Approved WMOPending
To evaluate the efficacy of crovalimab compared to eculizumab